Lipiodol® Ultra Fluid
Discovered by Marcel Guerbet in 1901, Lipiodol® Ultra Fluid was the first iodinated contrast agent used in the world. It was first used in radiology in France in 1921.
Since 1980, Lipiodol® Ultra Fluid is developed in interventional radiology.
It is currently available in 47 countries.
Patent Blue V
Patent Blue V, which is not a contrast agent but rather a dye, was launched on the Belgian market in 1971.
Vectorio® is a mixing and injection system for Conventional Trans-Arterial Chemo-Embolization (cTACE).
Vectorio® is a set of Lipiodol Ultra Fluid resistant medical devices including syringes, patented stopcock and withdrawing devices.
SeQure® and DraKon™ microcatheters
SeQure® and DraKon™ are microcatheters for peripheral vessels embolization.
They are intended for:
SeQure® and Drakon™ microcatheters should not be used in cerebral vessels.
SeQure® is an innovative reflux control microcatheter that uses flow dynamics to create a fluid barrier.
DraKon™ is a standard microcatheter adapted for any peripheral embolizations (including cTACE).
SeQure® and DraKon™ have been authorized for commercialization in the United States by the FDA and is awaiting to be given a CE marking in Europe.